nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—ABCB1—Fluticasone furoate—asthma	0.0651	0.0883	CbGbCtD
Linagliptin—ABCB1—Indacaterol—asthma	0.0531	0.072	CbGbCtD
Linagliptin—CYP3A4—Fluticasone furoate—asthma	0.039	0.0529	CbGbCtD
Linagliptin—CYP3A4—Budesonide—asthma	0.0348	0.0472	CbGbCtD
Linagliptin—CYP3A4—Ciclesonide—asthma	0.0318	0.0431	CbGbCtD
Linagliptin—CYP3A4—Indacaterol—asthma	0.0318	0.0431	CbGbCtD
Linagliptin—CYP3A4—Salbutamol—asthma	0.0296	0.0401	CbGbCtD
Linagliptin—CYP3A4—Flunisolide—asthma	0.0296	0.0401	CbGbCtD
Linagliptin—CYP3A4—Salmeterol—asthma	0.0296	0.0401	CbGbCtD
Linagliptin—ABCB1—Loratadine—asthma	0.0283	0.0384	CbGbCtD
Linagliptin—CYP3A4—Ipratropium bromide—asthma	0.0263	0.0357	CbGbCtD
Linagliptin—CYP3A4—Zileuton—asthma	0.0263	0.0357	CbGbCtD
Linagliptin—ABCB1—Methylprednisolone—asthma	0.0259	0.0352	CbGbCtD
Linagliptin—CYP3A4—Fluticasone Propionate—asthma	0.0251	0.0341	CbGbCtD
Linagliptin—CYP3A4—Zafirlukast—asthma	0.0232	0.0315	CbGbCtD
Linagliptin—CYP3A4—Tiotropium—asthma	0.02	0.0271	CbGbCtD
Linagliptin—CYP3A4—Aminophylline—asthma	0.019	0.0258	CbGbCtD
Linagliptin—CYP3A4—Theophylline—asthma	0.0179	0.0243	CbGbCtD
Linagliptin—CYP3A4—Montelukast—asthma	0.017	0.023	CbGbCtD
Linagliptin—CYP3A4—Loratadine—asthma	0.017	0.023	CbGbCtD
Linagliptin—ABCB1—Betamethasone—asthma	0.0168	0.0229	CbGbCtD
Linagliptin—ABCB1—Prednisolone—asthma	0.0166	0.0226	CbGbCtD
Linagliptin—ABCB1—Hydrocortisone—asthma	0.0158	0.0214	CbGbCtD
Linagliptin—ABCB1—Prednisone—asthma	0.0157	0.0213	CbGbCtD
Linagliptin—CYP3A4—Methylprednisolone—asthma	0.0155	0.0211	CbGbCtD
Linagliptin—CYP3A4—Triamcinolone—asthma	0.0118	0.016	CbGbCtD
Linagliptin—CYP3A4—Betamethasone—asthma	0.0101	0.0137	CbGbCtD
Linagliptin—CYP3A4—Prednisolone—asthma	0.00996	0.0135	CbGbCtD
Linagliptin—ABCB1—Dexamethasone—asthma	0.0098	0.0133	CbGbCtD
Linagliptin—CYP3A4—Hydrocortisone—asthma	0.00944	0.0128	CbGbCtD
Linagliptin—CYP3A4—Prednisone—asthma	0.00941	0.0128	CbGbCtD
Linagliptin—CYP3A4—Dexamethasone—asthma	0.00587	0.00797	CbGbCtD
Linagliptin—DPP4—exocrine gland—asthma	0.00368	0.25	CbGeAlD
Linagliptin—DPP4—respiratory system—asthma	0.00192	0.13	CbGeAlD
Linagliptin—DPP4—epithelium—asthma	0.0016	0.109	CbGeAlD
Linagliptin—DPP4—smooth muscle tissue—asthma	0.00154	0.105	CbGeAlD
Linagliptin—DPP4—cardiovascular system—asthma	0.00147	0.0996	CbGeAlD
Linagliptin—DPP4—adrenal gland—asthma	0.00116	0.0788	CbGeAlD
Linagliptin—DPP4—lung—asthma	0.00102	0.069	CbGeAlD
Linagliptin—ABCB1—respiratory system—asthma	0.000443	0.03	CbGeAlD
Linagliptin—ABCB1—adrenal cortex—asthma	0.000371	0.0252	CbGeAlD
Linagliptin—ABCB1—epithelium—asthma	0.00037	0.0251	CbGeAlD
Linagliptin—Rash—Ciclesonide—asthma	0.000342	0.00138	CcSEcCtD
Linagliptin—Dermatitis—Ciclesonide—asthma	0.000342	0.00138	CcSEcCtD
Linagliptin—Back pain—Budesonide—asthma	0.000341	0.00137	CcSEcCtD
Linagliptin—Headache—Ciclesonide—asthma	0.00034	0.00137	CcSEcCtD
Linagliptin—ABCB1—cardiovascular system—asthma	0.000339	0.023	CbGeAlD
Linagliptin—Diarrhoea—Cromoglicic acid—asthma	0.000338	0.00136	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Loratadine—asthma	0.000337	0.00136	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Tiotropium—asthma	0.000336	0.00135	CcSEcCtD
Linagliptin—Cough—Formoterol—asthma	0.000336	0.00135	CcSEcCtD
Linagliptin—Cough—Arformoterol—asthma	0.000336	0.00135	CcSEcCtD
Linagliptin—Anaphylactic shock—Mometasone—asthma	0.000335	0.00135	CcSEcCtD
Linagliptin—Constipation—Loratadine—asthma	0.000334	0.00134	CcSEcCtD
Linagliptin—Constipation—Tiotropium—asthma	0.000333	0.00134	CcSEcCtD
Linagliptin—Infection—Mometasone—asthma	0.000333	0.00134	CcSEcCtD
Linagliptin—Angioedema—Salbutamol—asthma	0.000332	0.00134	CcSEcCtD
Linagliptin—Diabetes mellitus—Betamethasone—asthma	0.000332	0.00134	CcSEcCtD
Linagliptin—Diabetes mellitus—Dexamethasone—asthma	0.000332	0.00134	CcSEcCtD
Linagliptin—Hypersensitivity—Ipratropium bromide—asthma	0.000332	0.00134	CcSEcCtD
Linagliptin—Skin exfoliation—Prednisone—asthma	0.000331	0.00133	CcSEcCtD
Linagliptin—Cough—Montelukast—asthma	0.000329	0.00133	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Flunisolide—asthma	0.000329	0.00132	CcSEcCtD
Linagliptin—Urticaria—Aminophylline—asthma	0.000328	0.00132	CcSEcCtD
Linagliptin—Myalgia—Formoterol—asthma	0.000328	0.00132	CcSEcCtD
Linagliptin—Arthralgia—Arformoterol—asthma	0.000328	0.00132	CcSEcCtD
Linagliptin—Myalgia—Arformoterol—asthma	0.000328	0.00132	CcSEcCtD
Linagliptin—Arthralgia—Formoterol—asthma	0.000328	0.00132	CcSEcCtD
Linagliptin—ABCB1—trachea—asthma	0.000327	0.0222	CbGeAlD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—asthma	0.000326	0.00131	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—asthma	0.000326	0.00131	CcSEcCtD
Linagliptin—Angioedema—Budesonide—asthma	0.000322	0.0013	CcSEcCtD
Linagliptin—Hypersensitivity—Fluticasone Propionate—asthma	0.000321	0.00129	CcSEcCtD
Linagliptin—Arthralgia—Montelukast—asthma	0.000321	0.00129	CcSEcCtD
Linagliptin—Myalgia—Montelukast—asthma	0.000321	0.00129	CcSEcCtD
Linagliptin—Hypersensitivity—Salmeterol—asthma	0.000321	0.00129	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—asthma	0.000319	0.00128	CcSEcCtD
Linagliptin—Cough—Salbutamol—asthma	0.000318	0.00128	CcSEcCtD
Linagliptin—Anaphylactic shock—Arformoterol—asthma	0.000314	0.00127	CcSEcCtD
Linagliptin—Anaphylactic shock—Formoterol—asthma	0.000314	0.00127	CcSEcCtD
Linagliptin—Infection—Arformoterol—asthma	0.000312	0.00126	CcSEcCtD
Linagliptin—Infection—Formoterol—asthma	0.000312	0.00126	CcSEcCtD
Linagliptin—Rash—Cromoglicic acid—asthma	0.000311	0.00125	CcSEcCtD
Linagliptin—Dermatitis—Cromoglicic acid—asthma	0.000311	0.00125	CcSEcCtD
Linagliptin—Myalgia—Salbutamol—asthma	0.00031	0.00125	CcSEcCtD
Linagliptin—Arthralgia—Salbutamol—asthma	0.00031	0.00125	CcSEcCtD
Linagliptin—Urticaria—Tiotropium—asthma	0.00031	0.00125	CcSEcCtD
Linagliptin—Headache—Cromoglicic acid—asthma	0.000309	0.00124	CcSEcCtD
Linagliptin—Constipation—Flunisolide—asthma	0.000309	0.00124	CcSEcCtD
Linagliptin—Diarrhoea—Ipratropium bromide—asthma	0.000308	0.00124	CcSEcCtD
Linagliptin—Anaphylactic shock—Montelukast—asthma	0.000308	0.00124	CcSEcCtD
Linagliptin—Cough—Budesonide—asthma	0.000308	0.00124	CcSEcCtD
Linagliptin—Infection—Montelukast—asthma	0.000306	0.00123	CcSEcCtD
Linagliptin—Skin disorder—Arformoterol—asthma	0.000305	0.00123	CcSEcCtD
Linagliptin—Skin disorder—Formoterol—asthma	0.000305	0.00123	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Mometasone—asthma	0.000305	0.00123	CcSEcCtD
Linagliptin—Hypersensitivity—Aminophylline—asthma	0.000304	0.00123	CcSEcCtD
Linagliptin—Myalgia—Budesonide—asthma	0.0003	0.00121	CcSEcCtD
Linagliptin—Arthralgia—Budesonide—asthma	0.0003	0.00121	CcSEcCtD
Linagliptin—Skin disorder—Montelukast—asthma	0.000299	0.0012	CcSEcCtD
Linagliptin—Diarrhoea—Fluticasone Propionate—asthma	0.000298	0.0012	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Budesonide—asthma	0.000298	0.0012	CcSEcCtD
Linagliptin—Diarrhoea—Salmeterol—asthma	0.000298	0.0012	CcSEcCtD
Linagliptin—Anaphylactic shock—Salbutamol—asthma	0.000297	0.0012	CcSEcCtD
Linagliptin—Infection—Salbutamol—asthma	0.000295	0.00119	CcSEcCtD
Linagliptin—Pancreatitis—Prednisolone—asthma	0.000294	0.00118	CcSEcCtD
Linagliptin—Diabetes mellitus—Prednisone—asthma	0.00029	0.00117	CcSEcCtD
Linagliptin—Skin disorder—Salbutamol—asthma	0.000288	0.00116	CcSEcCtD
Linagliptin—Anaphylactic shock—Budesonide—asthma	0.000288	0.00116	CcSEcCtD
Linagliptin—Hypersensitivity—Tiotropium—asthma	0.000287	0.00116	CcSEcCtD
Linagliptin—Urticaria—Flunisolide—asthma	0.000287	0.00116	CcSEcCtD
Linagliptin—Pancreatitis—Hydrocortisone—asthma	0.000287	0.00115	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Arformoterol—asthma	0.000287	0.00115	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Formoterol—asthma	0.000287	0.00115	CcSEcCtD
Linagliptin—Infection—Budesonide—asthma	0.000286	0.00115	CcSEcCtD
Linagliptin—Rash—Ipratropium bromide—asthma	0.000284	0.00114	CcSEcCtD
Linagliptin—Dermatitis—Ipratropium bromide—asthma	0.000284	0.00114	CcSEcCtD
Linagliptin—Diarrhoea—Aminophylline—asthma	0.000283	0.00114	CcSEcCtD
Linagliptin—Headache—Ipratropium bromide—asthma	0.000282	0.00114	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Montelukast—asthma	0.000281	0.00113	CcSEcCtD
Linagliptin—Skin disorder—Budesonide—asthma	0.000279	0.00112	CcSEcCtD
Linagliptin—Rash—Fluticasone Propionate—asthma	0.000275	0.00111	CcSEcCtD
Linagliptin—Dermatitis—Fluticasone Propionate—asthma	0.000275	0.00111	CcSEcCtD
Linagliptin—Rash—Salmeterol—asthma	0.000274	0.0011	CcSEcCtD
Linagliptin—Dermatitis—Salmeterol—asthma	0.000274	0.0011	CcSEcCtD
Linagliptin—Headache—Fluticasone Propionate—asthma	0.000273	0.0011	CcSEcCtD
Linagliptin—Headache—Salmeterol—asthma	0.000273	0.0011	CcSEcCtD
Linagliptin—Weight increased—Prednisolone—asthma	0.000273	0.0011	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Hydrocortisone—asthma	0.000272	0.00109	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Arformoterol—asthma	0.000272	0.00109	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Formoterol—asthma	0.000272	0.00109	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Salbutamol—asthma	0.000271	0.00109	CcSEcCtD
Linagliptin—Pancreatitis—Triamcinolone—asthma	0.00027	0.00109	CcSEcCtD
Linagliptin—Pancreatitis—Methylprednisolone—asthma	0.000269	0.00108	CcSEcCtD
Linagliptin—Constipation—Formoterol—asthma	0.000269	0.00108	CcSEcCtD
Linagliptin—Constipation—Arformoterol—asthma	0.000269	0.00108	CcSEcCtD
Linagliptin—ABCB1—adrenal gland—asthma	0.000268	0.0182	CbGeAlD
Linagliptin—Diarrhoea—Loratadine—asthma	0.000267	0.00108	CcSEcCtD
Linagliptin—Weight increased—Hydrocortisone—asthma	0.000266	0.00107	CcSEcCtD
Linagliptin—Hypersensitivity—Flunisolide—asthma	0.000266	0.00107	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Montelukast—asthma	0.000266	0.00107	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Budesonide—asthma	0.000262	0.00106	CcSEcCtD
Linagliptin—Infestation NOS—Hydrocortisone—asthma	0.000261	0.00105	CcSEcCtD
Linagliptin—Infestation—Hydrocortisone—asthma	0.000261	0.00105	CcSEcCtD
Linagliptin—Rash—Aminophylline—asthma	0.000261	0.00105	CcSEcCtD
Linagliptin—Dermatitis—Aminophylline—asthma	0.00026	0.00105	CcSEcCtD
Linagliptin—Headache—Aminophylline—asthma	0.000259	0.00104	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Salbutamol—asthma	0.000256	0.00103	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Triamcinolone—asthma	0.000256	0.00103	CcSEcCtD
Linagliptin—Constipation—Salbutamol—asthma	0.000254	0.00102	CcSEcCtD
Linagliptin—Weight increased—Triamcinolone—asthma	0.000251	0.00101	CcSEcCtD
Linagliptin—Weight increased—Methylprednisolone—asthma	0.00025	0.00101	CcSEcCtD
Linagliptin—Urticaria—Arformoterol—asthma	0.00025	0.00101	CcSEcCtD
Linagliptin—Urticaria—Formoterol—asthma	0.00025	0.00101	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Budesonide—asthma	0.000248	0.001	CcSEcCtD
Linagliptin—Diarrhoea—Flunisolide—asthma	0.000247	0.000995	CcSEcCtD
Linagliptin—Rash—Loratadine—asthma	0.000246	0.000991	CcSEcCtD
Linagliptin—Constipation—Budesonide—asthma	0.000246	0.00099	CcSEcCtD
Linagliptin—Dermatitis—Loratadine—asthma	0.000246	0.00099	CcSEcCtD
Linagliptin—Rash—Tiotropium—asthma	0.000246	0.000989	CcSEcCtD
Linagliptin—Dermatitis—Tiotropium—asthma	0.000245	0.000988	CcSEcCtD
Linagliptin—Infestation NOS—Methylprednisolone—asthma	0.000245	0.000987	CcSEcCtD
Linagliptin—Infestation—Methylprednisolone—asthma	0.000245	0.000987	CcSEcCtD
Linagliptin—Urticaria—Montelukast—asthma	0.000245	0.000985	CcSEcCtD
Linagliptin—Headache—Loratadine—asthma	0.000245	0.000985	CcSEcCtD
Linagliptin—Headache—Tiotropium—asthma	0.000244	0.000983	CcSEcCtD
Linagliptin—Urticaria—Salbutamol—asthma	0.000236	0.00095	CcSEcCtD
Linagliptin—ABCB1—lung—asthma	0.000235	0.0159	CbGeAlD
Linagliptin—Hypersensitivity—Formoterol—asthma	0.000232	0.000933	CcSEcCtD
Linagliptin—Hypersensitivity—Arformoterol—asthma	0.000232	0.000933	CcSEcCtD
Linagliptin—Diarrhoea—Mometasone—asthma	0.000229	0.000923	CcSEcCtD
Linagliptin—Urticaria—Budesonide—asthma	0.000229	0.00092	CcSEcCtD
Linagliptin—Rash—Flunisolide—asthma	0.000228	0.000917	CcSEcCtD
Linagliptin—Dermatitis—Flunisolide—asthma	0.000228	0.000916	CcSEcCtD
Linagliptin—Weight increased—Betamethasone—asthma	0.000227	0.000916	CcSEcCtD
Linagliptin—Weight increased—Dexamethasone—asthma	0.000227	0.000916	CcSEcCtD
Linagliptin—Hypersensitivity—Montelukast—asthma	0.000227	0.000914	CcSEcCtD
Linagliptin—Headache—Flunisolide—asthma	0.000226	0.000911	CcSEcCtD
Linagliptin—Hypersensitivity—Salbutamol—asthma	0.000219	0.000881	CcSEcCtD
Linagliptin—Diarrhoea—Arformoterol—asthma	0.000215	0.000866	CcSEcCtD
Linagliptin—Diarrhoea—Formoterol—asthma	0.000215	0.000866	CcSEcCtD
Linagliptin—Pancreatitis—Prednisone—asthma	0.000213	0.000859	CcSEcCtD
Linagliptin—Hypersensitivity—Budesonide—asthma	0.000212	0.000853	CcSEcCtD
Linagliptin—Immune system disorder—Hydrocortisone—asthma	0.000211	0.000851	CcSEcCtD
Linagliptin—Rash—Mometasone—asthma	0.000211	0.000851	CcSEcCtD
Linagliptin—Dermatitis—Mometasone—asthma	0.000211	0.00085	CcSEcCtD
Linagliptin—Diarrhoea—Montelukast—asthma	0.000211	0.000849	CcSEcCtD
Linagliptin—Headache—Mometasone—asthma	0.00021	0.000845	CcSEcCtD
Linagliptin—Malnutrition—Hydrocortisone—asthma	0.000204	0.000821	CcSEcCtD
Linagliptin—Diarrhoea—Salbutamol—asthma	0.000203	0.000818	CcSEcCtD
Linagliptin—Immune system disorder—Methylprednisolone—asthma	0.000199	0.0008	CcSEcCtD
Linagliptin—Rash—Arformoterol—asthma	0.000198	0.000798	CcSEcCtD
Linagliptin—Rash—Formoterol—asthma	0.000198	0.000798	CcSEcCtD
Linagliptin—Mediastinal disorder—Methylprednisolone—asthma	0.000198	0.000798	CcSEcCtD
Linagliptin—Dermatitis—Arformoterol—asthma	0.000198	0.000798	CcSEcCtD
Linagliptin—Dermatitis—Formoterol—asthma	0.000198	0.000798	CcSEcCtD
Linagliptin—Weight increased—Prednisone—asthma	0.000198	0.000797	CcSEcCtD
Linagliptin—Headache—Arformoterol—asthma	0.000197	0.000793	CcSEcCtD
Linagliptin—Headache—Formoterol—asthma	0.000197	0.000793	CcSEcCtD
Linagliptin—Diarrhoea—Budesonide—asthma	0.000197	0.000792	CcSEcCtD
Linagliptin—Rash—Montelukast—asthma	0.000194	0.000782	CcSEcCtD
Linagliptin—Dermatitis—Montelukast—asthma	0.000194	0.000781	CcSEcCtD
Linagliptin—Headache—Montelukast—asthma	0.000193	0.000777	CcSEcCtD
Linagliptin—Malnutrition—Methylprednisolone—asthma	0.000191	0.000771	CcSEcCtD
Linagliptin—Angioedema—Prednisolone—asthma	0.000191	0.000768	CcSEcCtD
Linagliptin—Rash—Salbutamol—asthma	0.000187	0.000754	CcSEcCtD
Linagliptin—Dermatitis—Salbutamol—asthma	0.000187	0.000753	CcSEcCtD
Linagliptin—Angioedema—Hydrocortisone—asthma	0.000186	0.00075	CcSEcCtD
Linagliptin—Headache—Salbutamol—asthma	0.000186	0.000749	CcSEcCtD
Linagliptin—Back pain—Triamcinolone—asthma	0.000186	0.000747	CcSEcCtD
Linagliptin—Rash—Budesonide—asthma	0.000181	0.00073	CcSEcCtD
Linagliptin—Dermatitis—Budesonide—asthma	0.000181	0.00073	CcSEcCtD
Linagliptin—Headache—Budesonide—asthma	0.00018	0.000726	CcSEcCtD
Linagliptin—Angioedema—Triamcinolone—asthma	0.000175	0.000706	CcSEcCtD
Linagliptin—Angioedema—Methylprednisolone—asthma	0.000175	0.000704	CcSEcCtD
Linagliptin—Myalgia—Hydrocortisone—asthma	0.000174	0.000699	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	0.000172	0.000694	CcSEcCtD
Linagliptin—Anaphylactic shock—Prednisolone—asthma	0.00017	0.000686	CcSEcCtD
Linagliptin—Cough—Triamcinolone—asthma	0.000167	0.000674	CcSEcCtD
Linagliptin—Anaphylactic shock—Hydrocortisone—asthma	0.000166	0.00067	CcSEcCtD
Linagliptin—Infection—Hydrocortisone—asthma	0.000165	0.000665	CcSEcCtD
Linagliptin—Myalgia—Triamcinolone—asthma	0.000163	0.000658	CcSEcCtD
Linagliptin—Myalgia—Methylprednisolone—asthma	0.000163	0.000656	CcSEcCtD
Linagliptin—Arthralgia—Methylprednisolone—asthma	0.000163	0.000656	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	0.000162	0.000652	CcSEcCtD
Linagliptin—Skin disorder—Hydrocortisone—asthma	0.000162	0.000651	CcSEcCtD
Linagliptin—Angioedema—Betamethasone—asthma	0.000159	0.000641	CcSEcCtD
Linagliptin—Angioedema—Dexamethasone—asthma	0.000159	0.000641	CcSEcCtD
Linagliptin—Immune system disorder—Prednisone—asthma	0.000157	0.000634	CcSEcCtD
Linagliptin—Anaphylactic shock—Triamcinolone—asthma	0.000157	0.000631	CcSEcCtD
Linagliptin—Anaphylactic shock—Methylprednisolone—asthma	0.000156	0.000629	CcSEcCtD
Linagliptin—Infection—Triamcinolone—asthma	0.000156	0.000627	CcSEcCtD
Linagliptin—Infection—Methylprednisolone—asthma	0.000155	0.000625	CcSEcCtD
Linagliptin—Skin disorder—Methylprednisolone—asthma	0.000152	0.000611	CcSEcCtD
Linagliptin—Malnutrition—Prednisone—asthma	0.000152	0.000611	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Hydrocortisone—asthma	0.000152	0.00061	CcSEcCtD
Linagliptin—Myalgia—Betamethasone—asthma	0.000148	0.000597	CcSEcCtD
Linagliptin—Myalgia—Dexamethasone—asthma	0.000148	0.000597	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Hydrocortisone—asthma	0.000144	0.000578	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Triamcinolone—asthma	0.000143	0.000575	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Methylprednisolone—asthma	0.000142	0.000573	CcSEcCtD
Linagliptin—Anaphylactic shock—Dexamethasone—asthma	0.000142	0.000572	CcSEcCtD
Linagliptin—Anaphylactic shock—Betamethasone—asthma	0.000142	0.000572	CcSEcCtD
Linagliptin—Infection—Betamethasone—asthma	0.000141	0.000568	CcSEcCtD
Linagliptin—Infection—Dexamethasone—asthma	0.000141	0.000568	CcSEcCtD
Linagliptin—Angioedema—Prednisone—asthma	0.000139	0.000558	CcSEcCtD
Linagliptin—Urticaria—Prednisolone—asthma	0.000135	0.000545	CcSEcCtD
Linagliptin—Urticaria—Hydrocortisone—asthma	0.000132	0.000532	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Betamethasone—asthma	0.000129	0.000521	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Dexamethasone—asthma	0.000129	0.000521	CcSEcCtD
Linagliptin—Myalgia—Prednisone—asthma	0.000129	0.00052	CcSEcCtD
Linagliptin—Arthralgia—Prednisone—asthma	0.000129	0.00052	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	0.000128	0.000516	CcSEcCtD
Linagliptin—Hypersensitivity—Prednisolone—asthma	0.000125	0.000505	CcSEcCtD
Linagliptin—Urticaria—Triamcinolone—asthma	0.000124	0.000501	CcSEcCtD
Linagliptin—Urticaria—Methylprednisolone—asthma	0.000124	0.0005	CcSEcCtD
Linagliptin—Anaphylactic shock—Prednisone—asthma	0.000124	0.000498	CcSEcCtD
Linagliptin—Infection—Prednisone—asthma	0.000123	0.000495	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Dexamethasone—asthma	0.000123	0.000494	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Betamethasone—asthma	0.000123	0.000494	CcSEcCtD
Linagliptin—Hypersensitivity—Hydrocortisone—asthma	0.000123	0.000493	CcSEcCtD
Linagliptin—Skin disorder—Prednisone—asthma	0.00012	0.000484	CcSEcCtD
Linagliptin—Hypersensitivity—Triamcinolone—asthma	0.000115	0.000465	CcSEcCtD
Linagliptin—Hypersensitivity—Methylprednisolone—asthma	0.000115	0.000464	CcSEcCtD
Linagliptin—Diarrhoea—Hydrocortisone—asthma	0.000114	0.000458	CcSEcCtD
Linagliptin—Urticaria—Betamethasone—asthma	0.000113	0.000455	CcSEcCtD
Linagliptin—Urticaria—Dexamethasone—asthma	0.000113	0.000455	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Prednisone—asthma	0.000113	0.000454	CcSEcCtD
Linagliptin—Rash—Prednisolone—asthma	0.000107	0.000432	CcSEcCtD
Linagliptin—Dermatitis—Prednisolone—asthma	0.000107	0.000432	CcSEcCtD
Linagliptin—Diarrhoea—Methylprednisolone—asthma	0.000107	0.000431	CcSEcCtD
Linagliptin—Headache—Prednisolone—asthma	0.000107	0.00043	CcSEcCtD
Linagliptin—Constipation—Prednisone—asthma	0.000106	0.000426	CcSEcCtD
Linagliptin—Rash—Hydrocortisone—asthma	0.000105	0.000422	CcSEcCtD
Linagliptin—Dermatitis—Hydrocortisone—asthma	0.000105	0.000422	CcSEcCtD
Linagliptin—Headache—Hydrocortisone—asthma	0.000104	0.00042	CcSEcCtD
Linagliptin—Rash—Triamcinolone—asthma	9.88e-05	0.000398	CcSEcCtD
Linagliptin—Dermatitis—Triamcinolone—asthma	9.87e-05	0.000397	CcSEcCtD
Linagliptin—Rash—Methylprednisolone—asthma	9.85e-05	0.000397	CcSEcCtD
Linagliptin—Dermatitis—Methylprednisolone—asthma	9.84e-05	0.000396	CcSEcCtD
Linagliptin—Urticaria—Prednisone—asthma	9.83e-05	0.000396	CcSEcCtD
Linagliptin—Headache—Triamcinolone—asthma	9.81e-05	0.000395	CcSEcCtD
Linagliptin—Headache—Methylprednisolone—asthma	9.79e-05	0.000394	CcSEcCtD
Linagliptin—Diarrhoea—Dexamethasone—asthma	9.72e-05	0.000392	CcSEcCtD
Linagliptin—Diarrhoea—Betamethasone—asthma	9.72e-05	0.000392	CcSEcCtD
Linagliptin—Hypersensitivity—Prednisone—asthma	9.12e-05	0.000367	CcSEcCtD
Linagliptin—Rash—Betamethasone—asthma	8.96e-05	0.000361	CcSEcCtD
Linagliptin—Rash—Dexamethasone—asthma	8.96e-05	0.000361	CcSEcCtD
Linagliptin—Dermatitis—Dexamethasone—asthma	8.95e-05	0.00036	CcSEcCtD
Linagliptin—Dermatitis—Betamethasone—asthma	8.95e-05	0.00036	CcSEcCtD
Linagliptin—Headache—Dexamethasone—asthma	8.9e-05	0.000358	CcSEcCtD
Linagliptin—Headache—Betamethasone—asthma	8.9e-05	0.000358	CcSEcCtD
Linagliptin—Diarrhoea—Prednisone—asthma	8.47e-05	0.000341	CcSEcCtD
Linagliptin—Rash—Prednisone—asthma	7.8e-05	0.000314	CcSEcCtD
Linagliptin—Dermatitis—Prednisone—asthma	7.8e-05	0.000314	CcSEcCtD
Linagliptin—Headache—Prednisone—asthma	7.75e-05	0.000312	CcSEcCtD
